Peringatan Keamanan

Mouse LD50 775mg/kg (intraperitoneal)
Mouse LD50 : 7600mg/kg (oral)
Rat LD 50 : 8100mg/kg (oral)
Rat LD50 176mg/kg (intravenous)
Severe toxicity occurs most often after intravenous infusions. It can also occur after chronic excessive oral doses, often in patients with renal insufficiency. Early manifestations are lethargy, hyporeflexia, followed by weakness, paralysis, hypotension, ECG changes (prolonged PR and QRS intervals), CNS depression, seizures, and respiratory depression. In overdose, magnesium impairs neuromuscular transmission, manifested as weakness and hyporeflexia.

Magnesium chloride

DB09407

small molecule approved

Deskripsi

Magnesium chloride salts are highly soluble in water and the hydrated form of magnesium chloride can be extracted from brine or sea water.

Struktur Molekul 2D

Berat 95.211
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) Elimination half-life has been reported to be 27.7 hours following an overdose of 400 mEq magnesium in an adult.
Volume Distribusi Bone (50% to 60%); extracellular fluid (1% to 2%)
Klirens (Clearance) Maximum magnesium clearance is directly proportional to creatinine clearance.

Absorpsi

Oral: Inversely proportional to amount ingested; 40% to 60% under controlled dietary conditions; 15% to 36% at higher doses

Metabolisme

Magnesium levels are efficiently regulated by the kidneys. Magnesium also undergoes efficient enterohepatic circulation

Rute Eliminasi

Magnesium is excreted in urine. Unabsorbed magnesium is excreted in feces

Interaksi Makanan

1 Data
  • 1. Take with or without food. Taking magnesium supplements with food may reduce the risk of diarrhea.

Interaksi Obat

906 Data
Succinylcholine The therapeutic efficacy of Succinylcholine can be increased when used in combination with Magnesium chloride.
Metocurine iodide The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Magnesium chloride.
Gallamine triethiodide The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Magnesium chloride.
Cisatracurium Magnesium chloride may increase the neuromuscular blocking activities of Cisatracurium.
Rocuronium The therapeutic efficacy of Rocuronium can be increased when used in combination with Magnesium chloride.
Atracurium besylate The therapeutic efficacy of Atracurium besylate can be increased when used in combination with Magnesium chloride.
Doxacurium The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium chloride.
Mivacurium The therapeutic efficacy of Mivacurium can be increased when used in combination with Magnesium chloride.
Decamethonium The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium chloride.
Metocurine The therapeutic efficacy of Metocurine can be increased when used in combination with Magnesium chloride.
Pancuronium The therapeutic efficacy of Pancuronium can be increased when used in combination with Magnesium chloride.
Pipecuronium The therapeutic efficacy of Pipecuronium can be increased when used in combination with Magnesium chloride.
Vecuronium The therapeutic efficacy of Vecuronium can be increased when used in combination with Magnesium chloride.
Rapacuronium The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium chloride.
Pyrantel The therapeutic efficacy of Pyrantel can be increased when used in combination with Magnesium chloride.
Neosaxitoxin The therapeutic efficacy of Neosaxitoxin can be increased when used in combination with Magnesium chloride.
Atracurium The therapeutic efficacy of Atracurium can be increased when used in combination with Magnesium chloride.
Gallamine The therapeutic efficacy of Gallamine can be increased when used in combination with Magnesium chloride.
Alcuronium The therapeutic efficacy of Alcuronium can be increased when used in combination with Magnesium chloride.
Tubocurarine The therapeutic efficacy of Tubocurarine can be increased when used in combination with Magnesium chloride.
Calcitriol The serum concentration of Magnesium chloride can be increased when it is combined with Calcitriol.
Calcifediol The serum concentration of Magnesium chloride can be increased when it is combined with Calcifediol.
Ergocalciferol The serum concentration of Magnesium chloride can be increased when it is combined with Ergocalciferol.
Cholecalciferol The serum concentration of Magnesium chloride can be increased when it is combined with Cholecalciferol.
Paricalcitol The serum concentration of Magnesium chloride can be increased when it is combined with Paricalcitol.
Dihydrotachysterol The serum concentration of Magnesium chloride can be increased when it is combined with Dihydrotachysterol.
Alfacalcidol The serum concentration of Magnesium chloride can be increased when it is combined with Alfacalcidol.
Seocalcitol The serum concentration of Magnesium chloride can be increased when it is combined with Seocalcitol.
Inecalcitol The serum concentration of Magnesium chloride can be increased when it is combined with Inecalcitol.
Becocalcidiol The serum concentration of Magnesium chloride can be increased when it is combined with Becocalcidiol.
Eldecalcitol The serum concentration of Magnesium chloride can be increased when it is combined with Eldecalcitol.
1alpha,24S-Dihydroxyvitamin D2 The serum concentration of Magnesium chloride can be increased when it is combined with 1alpha,24S-Dihydroxyvitamin D2.
Elocalcitol The serum concentration of Magnesium chloride can be increased when it is combined with Elocalcitol.
Maxacalcitol The serum concentration of Magnesium chloride can be increased when it is combined with Maxacalcitol.
Doxercalciferol The serum concentration of Magnesium chloride can be increased when it is combined with Doxercalciferol.
Vitamin D The serum concentration of Magnesium chloride can be increased when it is combined with Vitamin D.
1alpha-Hydroxyvitamin D5 The serum concentration of Magnesium chloride can be increased when it is combined with 1alpha-Hydroxyvitamin D5.
Previtamin D(3) The serum concentration of Magnesium chloride can be increased when it is combined with Previtamin D(3).
Deferiprone Magnesium chloride can cause a decrease in the absorption of Deferiprone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Eltrombopag Magnesium chloride can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.
Raltegravir Magnesium chloride can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deferasirox Magnesium chloride can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.
Halofantrine Magnesium chloride can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Misoprostol The risk or severity of adverse effects can be increased when Magnesium chloride is combined with Misoprostol.
Moxifloxacin Magnesium chloride can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Grepafloxacin Magnesium chloride can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Enoxacin Magnesium chloride can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pefloxacin Magnesium chloride can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ciprofloxacin Magnesium chloride can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trovafloxacin Magnesium chloride can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nalidixic acid Magnesium chloride can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rosoxacin Magnesium chloride can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cinoxacin Magnesium chloride can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Lomefloxacin Magnesium chloride can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gatifloxacin Magnesium chloride can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Norfloxacin Magnesium chloride can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levofloxacin Magnesium chloride can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ofloxacin Magnesium chloride can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sparfloxacin Magnesium chloride can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Temafloxacin Magnesium chloride can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fleroxacin Magnesium chloride can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Technetium Tc-99m ciprofloxacin Magnesium chloride can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Garenoxacin Magnesium chloride can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nemonoxacin Magnesium chloride can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Flumequine Magnesium chloride can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Enrofloxacin Magnesium chloride can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Orbifloxacin Magnesium chloride can cause a decrease in the absorption of Orbifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sarafloxacin Magnesium chloride can cause a decrease in the absorption of Sarafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Difloxacin Magnesium chloride can cause a decrease in the absorption of Difloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pazufloxacin Magnesium chloride can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prulifloxacin Magnesium chloride can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Delafloxacin Magnesium chloride can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sitafloxacin Magnesium chloride can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxolinic acid Magnesium chloride can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rufloxacin Magnesium chloride can cause a decrease in the absorption of Rufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pipemidic acid Magnesium chloride can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Lymecycline Magnesium chloride can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Clomocycline Magnesium chloride can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxytetracycline Magnesium chloride can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Demeclocycline Magnesium chloride can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tetracycline Magnesium chloride can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metacycline Magnesium chloride can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Minocycline Magnesium chloride can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sarecycline Magnesium chloride can cause a decrease in the absorption of Sarecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Omadacycline Magnesium chloride can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Penimepicycline Magnesium chloride can cause a decrease in the absorption of Penimepicycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Isradipine The risk or severity of hypotension can be increased when Magnesium chloride is combined with Isradipine.
Diltiazem The risk or severity of hypotension can be increased when Magnesium chloride is combined with Diltiazem.
Trimethadione The risk or severity of hypotension can be increased when Magnesium chloride is combined with Trimethadione.
Amlodipine The risk or severity of hypotension can be increased when Magnesium chloride is combined with Amlodipine.
Nimodipine The risk or severity of hypotension can be increased when Magnesium chloride is combined with Nimodipine.
Nisoldipine The risk or severity of hypotension can be increased when Magnesium chloride is combined with Nisoldipine.
Lercanidipine The risk or severity of hypotension can be increased when Magnesium chloride is combined with Lercanidipine.
Cinnarizine The risk or severity of hypotension can be increased when Magnesium chloride is combined with Cinnarizine.
Ethosuximide The risk or severity of hypotension can be increased when Magnesium chloride is combined with Ethosuximide.
Nicardipine The risk or severity of hypotension can be increased when Magnesium chloride is combined with Nicardipine.
Magnesium sulfate The risk or severity of hypotension can be increased when Magnesium chloride is combined with Magnesium sulfate.
Verapamil The risk or severity of hypotension can be increased when Magnesium chloride is combined with Verapamil.
Zonisamide The risk or severity of hypotension can be increased when Magnesium chloride is combined with Zonisamide.
Felodipine The risk or severity of hypotension can be increased when Magnesium chloride is combined with Felodipine.

Referensi & Sumber

Contoh Produk & Brand

Produk: 809 • International brands: 0
Produk
  • 2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose
    Solution • - • Intravenous • Canada • Approved
  • 2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Clinimix
    Solution • - • Intravenous • Canada • Approved
  • 2.5%travasol Amino Acid InJ.W.eleC.W.25%dex
    Liquid • - • Intravenous • Canada • Approved
  • 2.75% Travas. Amino Acid InJ.W.elecw.25%dex
    Liquid • - • Intravenous • Canada • Approved
  • 2.75% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose Quickmix
    Solution • - • Intravenous • Canada • Approved
  • 2.75% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix
    Solution • - • Intravenous • Canada • Approved
  • 2.75%travasol Amino Acid InJ.W.eleC.W.5%dex.
    Liquid • - • Intravenous • Canada • Approved
  • 4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose
    Solution • - • Intravenous • Canada • Approved
Menampilkan 8 dari 809 produk.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul